HEADER HYDROLASE/HYDROLASE INHIBITOR 16-OCT-94 3HAT TITLE ACTIVE SITE MIMETIC INHIBITION OF THROMBIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-THROMBIN (SMALL SUBUNIT); COMPND 3 CHAIN: L; COMPND 4 EC: 3.4.21.5; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ALPHA-THROMBIN (LARGE SUBUNIT); COMPND 7 CHAIN: H; COMPND 8 EC: 3.4.21.5; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: HIRUGEN; COMPND 11 CHAIN: I; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: FPAM (FIBRINOPEPTIDE A MIMIC); COMPND 15 CHAIN: T; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: BLOOD; SOURCE 6 TISSUE: BLOOD; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 ORGAN: BLOOD; SOURCE 12 TISSUE: BLOOD; SOURCE 13 MOL_ID: 3; SOURCE 14 MOL_ID: 4; SOURCE 15 SYNTHETIC: YES KEYWDS COMPLEX (SERINE PROTEASE-INHIBITOR), COMPLEX (SERINE PROTEASE- KEYWDS 2 INHIBITOR) COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.TULINSKY,I.I.MATHEWS REVDAT 3 13-JUL-11 3HAT 1 VERSN REVDAT 2 24-FEB-09 3HAT 1 VERSN REVDAT 1 27-FEB-95 3HAT 0 SPRSDE 27-FEB-95 3HAT 2HAT JRNL AUTH I.I.MATHEWS,A.TULINSKY JRNL TITL ACTIVE-SITE MIMETIC INHIBITION OF THROMBIN. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 51 550 1995 JRNL REFN ISSN 0907-4449 JRNL PMID 15299843 JRNL DOI 10.1107/S0907444994013132 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.-P.WU,V.YEE,A.TULINSKY,R.A.CHRUSCIEL,H.NAKANISHI,R.SHEN, REMARK 1 AUTH 2 C.PRIEBE,M.KAHN REMARK 1 TITL THE STRUCTURE OF A DESIGNED PEPTIDOMIMETIC INHIBITOR COMPLEX REMARK 1 TITL 2 OF ALPHA-THROMBIN REMARK 1 REF PROTEIN ENG. V. 6 471 1993 REMARK 1 REFN ISSN 0269-2139 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.TULINSKY,X.QIU REMARK 1 TITL ACTIVE SITE AND EXOSITE BINDING OF ALPHA-THROMBIN REMARK 1 REF BLOOD COAGULATION V. 4 305 1993 REMARK 1 REF 2 FIBRINOLYSIS REMARK 1 REFN ISSN 0957-5235 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.E.NESHEIM,F.G.PRENDERGAST,K.G.MANN REMARK 1 TITL INTERACTIONS OF A FLUORESCENT ACTIVE-SITE-DIRECTED INHIBITOR REMARK 1 TITL 2 OF THROMBIN: DANSYLARGININE N-(3-ETHYL-1,5-PENTANEDIYL)AMIDE REMARK 1 REF BIOCHEMISTRY V. 18 996 1979 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.140 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2396 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 179 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : 5.700 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3HAT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.55000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.20000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.55000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.20000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, I, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH H 410 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 THROMBIN IS CLEAVED BETWEEN RESIDUES 15 AND 16. CHAIN REMARK 400 IDENTIFIER *L* IS USED FOR RESIDUES 1H - 15 AND CHAIN REMARK 400 IDENTIFIER *H* IS USED FOR RESIDUES 16 - 247. CHAIN REMARK 400 IDENTIFIER *I* IS USED FOR HIRUGEN, THE CARBOXYL TERMINUS REMARK 400 OF HIRUDIN, WHICH OCCUPIES THE EXOSITE. CHAIN IDENTIFIER REMARK 400 *T* IS USED FOR FPAM, A DESIGNED PEPTIDOMIMETIC INHIBITOR, REMARK 400 WHICH OCCUPIES THE ACTIVE SITE OF ALPHA THROMBIN. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR H 146A REMARK 465 TRP H 146B REMARK 465 THR H 146C REMARK 465 ALA H 146D REMARK 465 ASN H 146E REMARK 465 VAL H 146F REMARK 465 GLY H 146G REMARK 465 LYS H 146H REMARK 465 ASN I 53 REMARK 465 GLY I 54 REMARK 465 MBN T 301 REMARK 465 ABN T 302 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG L 14D CG CD NE CZ NH1 NH2 REMARK 470 ASN H 62 CB CG OD1 REMARK 470 LYS H 110 CB CG CD CE NZ REMARK 470 GLN H 151 CB CG CD OE1 NE2 REMARK 470 GLU H 192 CB CG CD OE1 OE2 REMARK 470 GLN H 244 CG CD OE1 NE2 REMARK 470 PHE H 245 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU H 247 CB CG CD OE1 OE2 REMARK 470 ASP I 55 CB CG OD1 OD2 REMARK 470 GLU I 58 CD OE1 OE2 REMARK 470 RNG T 303 C1 O1 CD CC CB C2 O2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG L 15 O PHE H 204A 1.83 REMARK 500 O LYS H 224 O HOH H 429 2.07 REMARK 500 N SER L 1E O LEU H 123 2.12 REMARK 500 OE2 GLU H 97A NH1 ARG H 175 2.13 REMARK 500 OG SER H 195 C ARG T 306 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O ASP L 14L NH1 ARG H 173 4556 2.07 REMARK 500 O GLY L 14M NH1 ARG H 173 4556 2.09 REMARK 500 CZ ARG L 15 O THR H 172 4556 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE L 1G O - C - N ANGL. DEV. = 12.0 DEGREES REMARK 500 SER L 1E CB - CA - C ANGL. DEV. = 12.3 DEGREES REMARK 500 ARG L 4 CG - CD - NE ANGL. DEV. = 16.1 DEGREES REMARK 500 ARG L 4 NE - CZ - NH1 ANGL. DEV. = 9.8 DEGREES REMARK 500 ARG L 4 NE - CZ - NH2 ANGL. DEV. = -5.4 DEGREES REMARK 500 LYS L 14A CA - CB - CG ANGL. DEV. = 16.2 DEGREES REMARK 500 THR L 14B O - C - N ANGL. DEV. = 9.9 DEGREES REMARK 500 GLU L 14H OE1 - CD - OE2 ANGL. DEV. = 12.6 DEGREES REMARK 500 GLU L 14H CG - CD - OE1 ANGL. DEV. = -12.5 DEGREES REMARK 500 ILE L 14K CB - CA - C ANGL. DEV. = 14.4 DEGREES REMARK 500 ASP L 14L C - N - CA ANGL. DEV. = 17.6 DEGREES REMARK 500 ARG L 15 CD - NE - CZ ANGL. DEV. = 13.7 DEGREES REMARK 500 ARG L 15 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ASP H 21 CB - CG - OD2 ANGL. DEV. = -7.3 DEGREES REMARK 500 LEU H 33 CB - CA - C ANGL. DEV. = 20.0 DEGREES REMARK 500 CYS H 42 CA - CB - SG ANGL. DEV. = 8.9 DEGREES REMARK 500 ASP H 49 CB - CG - OD2 ANGL. DEV. = 10.4 DEGREES REMARK 500 ARG H 50 NE - CZ - NH1 ANGL. DEV. = 5.0 DEGREES REMARK 500 ARG H 50 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 LEU H 60 CB - CG - CD2 ANGL. DEV. = -10.9 DEGREES REMARK 500 TYR H 60A CB - CG - CD2 ANGL. DEV. = 4.2 DEGREES REMARK 500 TYR H 60A CB - CG - CD1 ANGL. DEV. = -5.4 DEGREES REMARK 500 ASP H 60E CB - CG - OD1 ANGL. DEV. = -6.7 DEGREES REMARK 500 ASP H 60E CB - CG - OD2 ANGL. DEV. = 8.0 DEGREES REMARK 500 ASP H 63 CB - CG - OD1 ANGL. DEV. = -6.2 DEGREES REMARK 500 ASP H 63 O - C - N ANGL. DEV. = 9.9 DEGREES REMARK 500 LEU H 64 O - C - N ANGL. DEV. = 10.1 DEGREES REMARK 500 ARG H 67 CD - NE - CZ ANGL. DEV. = 12.9 DEGREES REMARK 500 ARG H 67 NH1 - CZ - NH2 ANGL. DEV. = -9.3 DEGREES REMARK 500 ARG H 67 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG H 67 NE - CZ - NH2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ARG H 73 CD - NE - CZ ANGL. DEV. = 13.3 DEGREES REMARK 500 ARG H 73 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 THR H 74 OG1 - CB - CG2 ANGL. DEV. = 14.3 DEGREES REMARK 500 THR H 74 N - CA - C ANGL. DEV. = 17.3 DEGREES REMARK 500 ARG H 75 CD - NE - CZ ANGL. DEV. = 18.3 DEGREES REMARK 500 ARG H 75 NH1 - CZ - NH2 ANGL. DEV. = -12.2 DEGREES REMARK 500 ARG H 75 NE - CZ - NH1 ANGL. DEV. = 12.4 DEGREES REMARK 500 ARG H 77A CD - NE - CZ ANGL. DEV. = 18.9 DEGREES REMARK 500 ARG H 77A NE - CZ - NH1 ANGL. DEV. = 6.7 DEGREES REMARK 500 ARG H 77A NE - CZ - NH2 ANGL. DEV. = -11.7 DEGREES REMARK 500 ARG H 77A CA - C - O ANGL. DEV. = -12.7 DEGREES REMARK 500 ASN H 78 C - N - CA ANGL. DEV. = -17.3 DEGREES REMARK 500 SER H 83 N - CA - CB ANGL. DEV. = 9.1 DEGREES REMARK 500 LEU H 85 O - C - N ANGL. DEV. = 12.4 DEGREES REMARK 500 ARG H 93 NE - CZ - NH1 ANGL. DEV. = -4.7 DEGREES REMARK 500 ARG H 93 NE - CZ - NH2 ANGL. DEV. = 3.8 DEGREES REMARK 500 TYR H 94 CB - CG - CD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 GLU H 97A OE1 - CD - OE2 ANGL. DEV. = 12.0 DEGREES REMARK 500 ASP H 102 OD1 - CG - OD2 ANGL. DEV. = 14.1 DEGREES REMARK 500 REMARK 500 THIS ENTRY HAS 91 ANGLE DEVIATIONS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER L 1E 92.62 112.62 REMARK 500 GLU L 1C -114.61 -71.58 REMARK 500 ALA L 1B -35.95 -139.22 REMARK 500 PHE L 7 -83.70 -134.48 REMARK 500 ILE L 14K 39.67 71.46 REMARK 500 ASP L 14L 105.82 75.41 REMARK 500 LEU H 59 -73.71 -89.55 REMARK 500 TYR H 60A 82.12 -166.94 REMARK 500 ASN H 60G 68.30 -166.16 REMARK 500 HIS H 71 -55.49 -133.09 REMARK 500 GLU H 77 78.86 -66.36 REMARK 500 ARG H 77A -75.78 -31.08 REMARK 500 LEU H 99 32.67 71.42 REMARK 500 ARG H 101 44.01 76.16 REMARK 500 ARG H 187 -164.79 -121.13 REMARK 500 GLN H 244 -59.00 -139.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 LYS L 14A 24.2 L L OUTSIDE RANGE REMARK 500 ARG H 77A 23.1 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH H 583 DISTANCE = 5.37 ANGSTROMS REMARK 525 HOH H 657 DISTANCE = 10.03 ANGSTROMS REMARK 525 HOH H 806 DISTANCE = 8.23 ANGSTROMS REMARK 525 HOH H 866 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH I 814 DISTANCE = 7.28 ANGSTROMS REMARK 525 HOH I 904 DISTANCE = 11.02 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF HIRUGEN REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN T OF FPAM (FIBRINOPEPTIDE REMARK 800 A MIMIC) DBREF 3HAT L 1H 15 UNP P00734 THRB_HUMAN 328 363 DBREF 3HAT H 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 3HAT I 53 64 UNP P09945 HIRV2_HIRME 53 64 DBREF 3HAT T 301 306 PDB 3HAT 3HAT 301 306 SEQRES 1 L 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 L 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 L 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 H 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 H 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 H 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 H 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 H 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 H 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 H 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 H 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 H 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 H 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 H 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 H 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 H 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 H 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 H 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 H 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 H 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 H 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 H 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 H 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 I 12 ASN GLY ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU SEQRES 1 T 6 MBN ABN RNG GLY VAL ARG MODRES 3HAT TYS I 63 TYR O-SULFO-L-TYROSINE HET TYS I 63 16 HET RNG T 303 9 HETNAM TYS O-SULFO-L-TYROSINE HETNAM RNG (6,10-DIOXO-OCTAHYDRO-PYRIDAZINO[1,2-A][1,2]DIAZEPIN-1- HETNAM 2 RNG YL)-ACETALDEHYDE FRAGMENT HETSYN RNG FUSED RING FRAGMENT OF INHIBITOR FORMUL 3 TYS C9 H11 N O6 S FORMUL 4 RNG C11 H16 N2 O3 FORMUL 5 HOH *179(H2 O) HELIX 1 H1 ALA H 55 LEU H 60 1 6 HELIX 2 H2 GLU H 164 SER H 171 1 8 HELIX 3 H3 ASP H 125 LEU H 129C 1 8 HELIX 4 H4 VAL H 231 GLN H 244 1 14 SHEET 1 B1 7 PRO H 28 ARG H 35 0 SHEET 2 B1 7 CYS H 42 ASP H 49 -1 SHEET 3 B1 7 ARG H 50 ALA H 56 -1 SHEET 4 B1 7 ARG H 101 LYS H 110 -1 SHEET 5 B1 7 LYS H 81 PRO H 92 -1 SHEET 6 B1 7 ASP H 63 GLY H 69 -1 SHEET 7 B1 7 PRO H 28 ARG H 35 -1 SHEET 1 B2 7 GLY H 133 TRP H 141 0 SHEET 2 B2 7 LEU H 155 ILE H 162 -1 SHEET 3 B2 7 ASN H 179 PRO H 186 -1 SHEET 4 B2 7 GLY H 223 THR H 229 -1 SHEET 5 B2 7 ILE H 212 GLU H 217 -1 SHEET 6 B2 7 GLY H 193 MET H 201 -1 SHEET 7 B2 7 GLY H 133 TRP H 141 -1 SSBOND 1 CYS L 1 CYS H 122 1555 1555 2.04 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.03 SSBOND 3 CYS H 168 CYS H 182 1555 1555 2.03 SSBOND 4 CYS H 191 CYS H 220 1555 1555 2.06 LINK C TYS I 63 N LEU I 64 1555 1555 1.33 LINK C RNG T 303 N GLY T 304 1555 1555 1.32 LINK C GLU I 62 N TYS I 63 1555 1555 1.34 CISPEP 1 SER H 36A PRO H 37 0 -1.35 SITE 1 CAT 3 HIS H 57 ASP H 102 SER H 195 SITE 1 AC1 13 PHE H 34 LYS H 36 GLN H 38 LEU H 65 SITE 2 AC1 13 ARG H 73 THR H 74 ARG H 75 TYR H 76 SITE 3 AC1 13 ILE H 82 MET H 84 HOH H 504 HOH I 426 SITE 4 AC1 13 HOH I 659 SITE 1 AC2 16 HIS H 57 TYR H 60A TRP H 60D LEU H 99 SITE 2 AC2 16 ILE H 174 ASP H 189 ALA H 190 GLY H 193 SITE 3 AC2 16 SER H 195 SER H 214 TRP H 215 GLY H 216 SITE 4 AC2 16 GLY H 219 HOH H 407 HOH H 571 HOH T 509 CRYST1 71.100 72.400 73.000 90.00 101.00 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014065 0.000000 0.002734 0.00000 SCALE2 0.000000 0.013812 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013955 0.00000